Literature DB >> 27956345

Intelligent substance delivery into cells using cell-penetrating peptides.

Toshihiko Tashima1.   

Abstract

Cell-penetrating peptides (CPPs) are oligopeptides that can permeate the cell membrane. The use of a CPP-mediated transport system could be an excellent method for delivering cell-impermeable substances such as proteins, antibodies, antisense oligonucleotides, siRNAs, plasmids, drugs, fluorescent compounds, and nanoparticles as covalently or noncovalently conjugated cargo into cells. Nonetheless, the mechanisms through which CPPs are internalized remain unclear. Endocytosis and direct translocation through the membrane are the generally accepted routes. Internalization via both pathways can occur simultaneously, depending on cellular conditions. However, the peculiar property of CPPs has attracted many researchers, especially in drug discovery or development, who intend to deliver impermeable substances into cells through the cell membrane. The delivery of drugs using CPPs may non-invasively solve the problem of drug penetration into cells with the added benefit of low cytotoxicity. Moreover, macromolecules can also be delivered by this transport system. In this review, I discuss the possibilities and advantages of substance delivery into cells using CPPs.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell-penetrating peptide; Drug delivery; Drug design; Membrane permeation; Protein transduction domain

Mesh:

Substances:

Year:  2016        PMID: 27956345     DOI: 10.1016/j.bmcl.2016.11.083

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  17 in total

Review 1.  Stimuli-responsive nanocarriers for intracellular delivery.

Authors:  Lemmuel L Tayo
Journal:  Biophys Rev       Date:  2017-11-25

Review 2.  Accessing Intracellular Targets through Nanocarrier-Mediated Cytosolic Protein Delivery.

Authors:  Ritabrita Goswami; Taewon Jeon; Harini Nagaraj; Shumei Zhai; Vincent M Rotello
Journal:  Trends Pharmacol Sci       Date:  2020-09-02       Impact factor: 14.819

3.  Improving Cell Penetration of Gold Nanorods by Using an Amphipathic Arginine Rich Peptide.

Authors:  Ana L Riveros; Cynthia Eggeling; Sebastián Riquelme; Carolina Adura; Carmen López-Iglesias; Fanny Guzmán; Eyleen Araya; Mario Almada; Josué Juárez; Miguel A Valdez; Ignacio A Fuentevilla; Olga López; Marcelo J Kogan
Journal:  Int J Nanomedicine       Date:  2020-03-17

Review 4.  The therapeutic landscape of HIV-1 via genome editing.

Authors:  Alexander Kwarteng; Samuel Terkper Ahuno; Godwin Kwakye-Nuako
Journal:  AIDS Res Ther       Date:  2017-07-14       Impact factor: 2.250

Review 5.  Trigger-Responsive Gene Transporters for Anticancer Therapy.

Authors:  Santhosh Kalash Rajendrakumar; Saji Uthaman; Chong Su Cho; In-Kyu Park
Journal:  Nanomaterials (Basel)       Date:  2017-05-26       Impact factor: 5.076

Review 6.  miRNAs in Tuberculosis: New Avenues for Diagnosis and Host-Directed Therapy.

Authors:  Naveed Sabir; Tariq Hussain; Syed Zahid Ali Shah; Antonio Peramo; Deming Zhao; Xiangmei Zhou
Journal:  Front Microbiol       Date:  2018-03-29       Impact factor: 5.640

Review 7.  In Vitro Assays: Friends or Foes of Cell-Penetrating Peptides.

Authors:  Jinsha Liu; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2020-07-02       Impact factor: 5.923

8.  Optimization of Inhibitory Peptides Targeting Phosphoprotein of Rabies Virus.

Authors:  Yongzhong Lu; Linyue Cheng; Jie Liu
Journal:  Int J Pept Res Ther       Date:  2019-08-13       Impact factor: 1.931

9.  M918: A Novel Cell Penetrating Peptide for Effective Delivery of HIV-1 Nef and Hsp20-Nef Proteins into Eukaryotic Cell Lines.

Authors:  Bahareh Rostami; Shiva Irani; Azam Bolhassani; Reza Ahangari Cohan
Journal:  Curr HIV Res       Date:  2018       Impact factor: 1.581

10.  Validation of Molecular Dynamics Simulations for Prediction of Three-Dimensional Structures of Small Proteins.

Authors:  Koichi Kato; Tomoki Nakayoshi; Shuichi Fukuyoshi; Eiji Kurimoto; Akifumi Oda
Journal:  Molecules       Date:  2017-10-12       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.